These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32502268)

  • 1. Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice.
    Lysenko V; Wildner-Verhey van Wijk N; Zimmermann K; Weller MC; Bühler M; Wildschut MHE; Schürch P; Fritz C; Wagner U; Calabresi L; Psaila B; Flavell RA; Vannucchi AM; Mead AJ; Wild PJ; Dirnhofer S; Manz MG; Theocharides APA
    Blood Adv; 2020 Jun; 4(11):2477-2488. PubMed ID: 32502268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood CD34
    Saito Y; Ellegast JM; Rafiei A; Song Y; Kull D; Heikenwalder M; Rongvaux A; Halene S; Flavell RA; Manz MG
    Blood; 2016 Oct; 128(14):1829-1833. PubMed ID: 27543436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells.
    Radtke S; Chan YY; Sippel TR; Kiem HP; Rongvaux A
    Exp Hematol; 2019 Feb; 70():31-41.e1. PubMed ID: 30590092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.
    Mazurier F; Fontanellas A; Salesse S; Taine L; Landriau S; Moreau-Gaudry F; Reiffers J; Peault B; Di Santo JP; de Verneuil H
    J Interferon Cytokine Res; 1999 May; 19(5):533-41. PubMed ID: 10386866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
    Wang X; Prakash S; Lu M; Tripodi J; Ye F; Najfeld V; Li Y; Schwartz M; Weinberg R; Roda P; Orazi A; Hoffman R
    J Clin Invest; 2012 Nov; 122(11):3888-99. PubMed ID: 23023702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
    Yoshimi A; Balasis ME; Vedder A; Feldman K; Ma Y; Zhang H; Lee SC; Letson C; Niyongere S; Lu SX; Ball M; Taylor J; Zhang Q; Zhao Y; Youssef S; Chung YR; Zhang XJ; Durham BH; Yang W; List AF; Loh ML; Klimek V; Berger MF; Stieglitz E; Padron E; Abdel-Wahab O
    Blood; 2017 Jul; 130(4):397-407. PubMed ID: 28576879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.
    Lu M; Xia L; Li Y; Wang X; Hoffman R
    Blood; 2014 Jul; 124(5):771-9. PubMed ID: 24869939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
    Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
    Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
    McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
    Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.
    Xu M; Bruno E; Chao J; Ni H; Lindgren V; Nunez R; Mahmud N; Finazzi G; Fruchtman SM; Popat U; Liu E; Prchal JT; Rondelli D; Barosi G; Hoffman R
    Blood; 2005 Feb; 105(4):1699-705. PubMed ID: 15471948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.
    Brehm MA; Cuthbert A; Yang C; Miller DM; DiIorio P; Laning J; Burzenski L; Gott B; Foreman O; Kavirayani A; Herlihy M; Rossini AA; Shultz LD; Greiner DL
    Clin Immunol; 2010 Apr; 135(1):84-98. PubMed ID: 20096637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.
    Wang X; Hu CS; Petersen B; Qiu J; Ye F; Houldsworth J; Eng K; Huang F; Hoffman R
    Blood Adv; 2018 Sep; 2(18):2378-2388. PubMed ID: 30242099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
    Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in umbilical cord blood stem cell expansion and clinical translation.
    Pineault N; Abu-Khader A
    Exp Hematol; 2015 Jul; 43(7):498-513. PubMed ID: 25970610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
    Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
    Front Immunol; 2020; 11():573406. PubMed ID: 33193358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Human CD8(+)TCR(-) Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγ(null) Mouse Model.
    Huang Y; Elliott MJ; Yolcu ES; Miller TO; Ratajczak J; Bozulic LD; Wen Y; Xu H; Ratajczak MZ; Ildstad ST
    Am J Transplant; 2016 Feb; 16(2):440-53. PubMed ID: 26550777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.
    Lepus CM; Gibson TF; Gerber SA; Kawikova I; Szczepanik M; Hossain J; Ablamunits V; Kirkiles-Smith N; Herold KC; Donis RO; Bothwell AL; Pober JS; Harding MJ
    Hum Immunol; 2009 Oct; 70(10):790-802. PubMed ID: 19524633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.